Automatic detection of pulmonary nodules: Evaluation of performance using two different MDCT scanners

The purpose of this study was to evaluate the diagnostic performance of a computer-aided diagnosis (CAD) system, on the detection of pulmonary nodules in multidetector row computed tomography (MDCT) images, by using two different MDCT scanners. The computerized scheme was based on the iris filter. We have collected CT cases of patients with pulmonary nodules. We have included in the study one hundred and thirty-two calcified and noncalcified nodules, measuring 4-30 mm in diameter. CT examinations were performed by using two different equipments: a CT scanner (SOMATOM Emotion 6), and a dual-source computed tomography system (SOMATOM Definition) (Siemens Medical System, Forchheim, Germany), with the following parameters: collimation, 6x1.0mm (Emotion 6); and 64×0.6mm (Definition); 100-130 kV; 70-110 mAs. Data were reconstructed with a slice thickness of 1.25mm (Emotion 6) and 1mm (Definition). True positive cases were determined by an independent interpretation of the study by three experienced chest radiologists, the panel decision being used as the reference standard. Free-response Receiver Operating Characteristic curves, sensitivity and number of false-positive per scan, were calculated. Our CAD scheme, for the test set of the study, yielded a sensitivity of 80%, with an average of 5.2 FPs per examination. At an average false positive rate of 9 per scan, our CAD scheme achieved sensitivities of 94% for all nodules, 94.5% for solid, 80% for non-solid, 84% for spiculated, and 97% for non-spiculated nodules. These encouraging results suggest that our CAD system, advocated as a second reader, may help radiologists in the detection of lung nodules in MDCTThis work has been partially supported by the Xunta de Galicia (expte. nº PGIDIT06BTF20802PR), and by the FIS (expte. nº PI060058) and (expte. nº PI080072)S

Risk factors for Coronavirus disease 2019 (Covid-19) death in a population cohort study from the Western Cape province, South Africa

Risk factors for coronavirus disease 2019 (COVID-19) death in sub-Saharan Africa and the effects of human immunodeficiency virus (HIV) and tuberculosis on COVID-19 outcomes are unknown. We conducted a population cohort study using linked data from adults attending public-sector health facilities in the Western Cape, South Africa. We used Cox proportional hazards models, adjusted for age, sex, location, and comorbidities, to examine the associations between HIV, tuberculosis, and COVID-19 death from 1 March to 9 June 2020 among (1) public-sector “active patients” (≥1 visit in the 3 years before March 2020); (2) laboratory-diagnosed COVID-19 cases; and (3) hospitalized COVID-19 cases. We calculated the standardized mortality ratio (SMR) for COVID-19, comparing adults living with and without HIV using modeled population estimates.Among 3 460 932 patients (16% living with HIV), 22 308 were diagnosed with COVID-19, of whom 625 died. COVID19 death was associated with male sex, increasing age, diabetes, hypertension, and chronic kidney disease. HIV was associated with COVID-19 mortality (adjusted hazard ratio [aHR], 2.14; 95% confidence interval [CI], 1.70–2.70), with similar risks across strata of viral loads and immunosuppression. Current and previous diagnoses of tuberculosis were associated with COVID-19 death (aHR, 2.70 [95% CI, 1.81–4.04] and 1.51 [95% CI, 1.18–1.93], respectively). The SMR for COVID-19 death associated with HIV was 2.39 (95% CI, 1.96–2.86); population attributable fraction 8.5% (95% CI, 6.1–11.1)